Your session is about to expire
← Back to Search
Tranexamic Acid for Postpartum Hemorrhage
Study Summary
This trial is testing if giving TXA to women during childbirth can help prevent postpartum hemorrhage, which is a major cause of maternal death.
- Postpartum Hemorrhage
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 29 Patients • NCT02063035Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are pregnant with twins or triplets.You are a woman who has had a blood clot in an artery or vein before.You have a history of seizures.You are allergic to tranexamic acid or other medications that prevent blood clots from breaking down.Women who have experienced bleeding in the space around the brain called subarachnoid hemorrhage.Women who have color vision problems they were not born with.
- Group 1: Cohort 1
- Group 2: Cohort 3
- Group 3: Cohort 2
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals aged 55 and above applicable for enrollment in this clinical experiment?
"This trial requires that prospective participants are between 18 and 49 years old, meeting the predefined age criteria."
What ailments has Tranexamic Acid been demonstrated to ameliorate?
"Tranexamic Acid is often recommended as a therapeutic solution for hyperfibrinolysis. Additionally, it has been found to be beneficial in the treatment of hemophilia, dental bleeding resulting from extractions, and other similar conditions."
What adverse reactions have been documented from Tranexamic Acid use?
"Evidence backing tranexamic acid's safety is still in its infancy, so it was assigned a score of 2 on the Power scale. This rating reflects that while there are some studies attesting to this medication's security, none have confirmed efficacy yet."
Is there a current call for participants in this experimental endeavor?
"At this juncture, this clinical trial is not recruiting new patients. First posted on February 1st 2018 and last updated October 17th 2022, it may be worth looking into the 362 trials for postpartum haemorrhage or the 61 studies concerning Tranexamic Acid that are actively seeking participants."
Has Tranexamic Acid been previously tested in a medical experiment?
"At present, 61 scientific trials for Tranexamic Acid are in progress. Of those studies, 26 have advanced to Phase 3. Kansas City is the epicentre of these experiments; however, 185 other sites around the world are carrying out research regarding this treatment."
How extensive is the participation in this clinical trial?
"This study has ceased recruitment processes for the time being. Initially posted on February 1st 2018, it was most recently updated on October 17th 2022. For those looking to participate in research related to postpartum hemorrhage, 362 trials are currently recruiting and 61 studies involving Tranexamic Acid are actively enrolling patients as well."
Who is eligible to sign up for the clinical trial?
"This clinical trial is admitting 30 individuals between 18 and 49 who have been diagnosed with postpartum hemorrhage. Furthermore, the American Congress of Obstetricians and Gynecologists criteria must be met for women undergoing medically indicated or elective cesarean section at greater than 34+0 weeks gestation or 39+0 weeks gestation respectively."
Share this study with friends
Copy Link
Messenger